Danish PCD & ChILD Centre, CF Centre Copenhagen, Pediatric Pulmonary Service, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Danish PCD & ChILD Centre, CF Centre Copenhagen, Pediatric Pulmonary Service, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Respir Med. 2017 Dec;133:42-47. doi: 10.1016/j.rmed.2017.10.027. Epub 2017 Nov 14.
Objectively assessing pulmonary disease is challenging in preschool children with asthma. We evaluated the feasibility of measuring fractional exhaled nitrogen oxide (FeNO) and multiple breath nitrogen washout (NMBW) in children. We compared their capacities for discriminating between children with asthma and healthy controls.
We measured FeNO and NMBW-derived indices of lung clearance (LCI) and conductive and acinar ventilation heterogeneity (S and S) in 65 preschool children; 35 with physician-diagnosed asthma and 30 healthy. FeNO was measured with a portable device (sampling time, 6 s). We employed data quality control guidelines on NMBW. Feasibility was evaluated in a maximum of 8 attempts for both methods. Atopic co-morbidity and first-degree disposition were evaluated with the ISAAC-questionnaire.
FeNO and NMBW testing were feasible in 45% and 91% of children, respectively. Feasibility was highly age-dependent. In children under 4 years old, FeNO was not feasible, but NMBW was 85% feasible. Children with asthma had significantly elevated S values (median; 95% CI) (0.024; 0.020; 0.029) compared to healthy controls (0.019; 0.016; 0.023), but similar FeNO, LCI and Svalues.
The feasibility of measuring FeNO was highly age-dependent and not applicable in children under age 4. NMBW was feasible in the majority of preschool children. S, but not FeNO, could discriminate between children with asthma and healthy controls.
客观评估学龄前哮喘儿童的肺部疾病具有挑战性。我们评估了测量呼出气一氧化氮分数(FeNO)和多次呼吸氮清除(NMBW)在儿童中的可行性。我们比较了它们区分哮喘儿童和健康对照的能力。
我们测量了 65 名学龄前儿童的 FeNO 和源自 NMBW 的肺清除指数(LCI)以及传导和腺泡通气异质性(S 和 S)的指标;35 名儿童被诊断为哮喘,30 名健康。FeNO 使用便携式设备测量(采样时间,6 秒)。我们对 NMBW 采用了数据质量控制指南。两种方法的可行性评估最多可进行 8 次尝试。特应性共病和一级亲属易感性通过 ISAAC 问卷进行评估。
FeNO 和 NMBW 测试的可行性分别为 45%和 91%。可行性高度依赖于年龄。在 4 岁以下的儿童中,FeNO 不可行,但 NMBW 可行率为 85%。与健康对照组相比,哮喘儿童的 S 值明显升高(中位数;95%CI)(0.024;0.020;0.029)(0.019;0.016;0.023),但 FeNO、LCI 和 S 值相似。
FeNO 测量的可行性高度依赖于年龄,4 岁以下的儿童无法测量。NMBW 在大多数学龄前儿童中是可行的。S,但不是 FeNO,可以区分哮喘儿童和健康对照。